Biogen BIIB Other — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Biogen’s 10-Q, filed July 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biogen's other — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biogen's other — revenue?
- Biogen (BIIB) reported other — revenue of $70.8M in Q2 2026.
- How has Biogen's other — revenue changed year-over-year?
- Biogen's other — revenue increased by 51.3% year-over-year, from $46.8M to $70.8M.
- What is the long-term trend for Biogen's other — revenue?
- Over 3 years (2021 to 2025), Biogen's other — revenue has grown at a 141.5% compound annual growth rate (CAGR), from $14M to $197.2M.
- What does other — revenue mean?
- This metric tracks the specific revenue stream attributed to the 'Other' business category, encompassing miscellaneous product sales or service fees. It serves as a catch-all for revenue sources that lack sufficient scale or distinct characteristics to warrant individual segment reporting. Analyzing this metric allows for a clearer understanding of the company's diversified revenue base beyond its core therapeutic or product franchises.